Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has approximately seven molecules, over two NCEs and approximately five NBEs in various stages of pre-clinical and clinical development. It is focused on developing and marketing branded and generic formulations. It focuses on manufacturing products across therapeutic areas of dermatology, respiratory and oncology. Its active pharmaceuticals ingredients (API) business spans over 80 countries, including regulated markets of the United States, Europe, Japan and Canada. Its products are primarily marketed in the United States and Western Europe. It has offices in over 40 countries, and operates approximately 20 manufacturing facilities in over five countries. It operates over five research and development (R&D) centers.

Pharmaceutical

Glenmark Pharmaceuticals

Glenn Saldanha

Indrajit Bose

Ulhas Dhuppad

Alind Sharma

Nikhil Amin

Brendan Ogrady

Sriram Venkatasubramanian

V. S. Mani

The Leadership Team at Glenmark Pharmaceuticals plays a crucial role in steering the company's strategic direction and ensuring operational excellence across its diverse global operations. Comprised of top executives from various domains such as research and development, operations, finance, and human resources, the team collaboratively drives innovation, oversees the development of new therapies, and enhances the quality and efficiency of manufacturing processes. Their collective expertise helps Glenmark maintain its competitive edge in the pharmaceutical industry while focusing on delivering high-quality, impactful medications to patients worldwide.

Leadership Team

Operations Team

Finance Team

Leadership Team

About

Team members

Other teams at Glenmark Pharmaceuticals

Operations Team

Finance Team